Grants and Contributions:
Title:
Device Miniaturization and In-Vitro Quality Study of the SIMBA Capsule
Agreement Number:
937687
Agreement Value:
$50,000.00
Agreement Date:
Nov 1, 2019 - Oct 31, 2020
Description:
Nimble Science has designed and implemented its first proof-of-concept prototype of the SIMBA capsules. The prototype is encapsulated by a standard AAA size gelatin capsule. The fact that gelatin is a type of animal-sourced material imposes a Class 4 device on SIMBA capsules as per the Guidance on the Risk-based Classification System by Health Canada. Therefore, this project involves miniaturizing a small intestine microbiome aspiration capsule in order to fit into a standard vegetarian enteric capsule for better patient acceptance and easier regulatory approval, and conducting a series of in-vitro tests to validate the sampling function parameters before proceeding to the clinical trial.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T2P 3P2
Reference Number:
172-2019-2020-Q3-937687
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
780882932
Recipient Type:
For-profit organization
Recipient's Legal Name:
Nimble Science Ltd.
Federal Riding Name:
Calgary Centre
Federal Riding Number:
48004
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512